Dr. Burt of Northwestern is apparently accepting patients who are interested in getting a hematopoietic stem cell transplant (similar to my HALT-MS experience) outside of a clinical trial. The cost is apparently in the $150,000 range. To my knowledge, this is the only facility in the US doing this procedure without requiring participation in a trial.
The difference with my therapy (BEAM) and this therapy (MIST) is best described by George Goss who runs the well-done blog http://themscure.blogspot.com/
"The other program, called the MIST trial pioneered by Dr. Richard Burt at Northwestern University recognizes that the fully ablative therapy is risky with approximately a 5% mortality. [Post transplant note: BEAM myeloablative treatment at Heidelberg University Hospital is actually closer to a low 1% mortality rate.] So Dr. Burt developed a regimen that is not fully myeloablative, but is instead lymphoablative which does not kill off 100% the bone marrow. This results in substantially reduced risk with a mortality rate of under 1%."
Dr. Burt is also recruiting for the below Phase III trial, which would be the same treatment (but participants are randomized, so one may be put into the control group). Of course it should be noted that going outside a clinical trial, especially if one qualifies, will not further research and will negate any chance of getting insurance to pay for it.
http://clinicaltrials.gov/ct2/show/N...cr=Open&rank=4
The difference with my therapy (BEAM) and this therapy (MIST) is best described by George Goss who runs the well-done blog http://themscure.blogspot.com/
"The other program, called the MIST trial pioneered by Dr. Richard Burt at Northwestern University recognizes that the fully ablative therapy is risky with approximately a 5% mortality. [Post transplant note: BEAM myeloablative treatment at Heidelberg University Hospital is actually closer to a low 1% mortality rate.] So Dr. Burt developed a regimen that is not fully myeloablative, but is instead lymphoablative which does not kill off 100% the bone marrow. This results in substantially reduced risk with a mortality rate of under 1%."
Dr. Burt is also recruiting for the below Phase III trial, which would be the same treatment (but participants are randomized, so one may be put into the control group). Of course it should be noted that going outside a clinical trial, especially if one qualifies, will not further research and will negate any chance of getting insurance to pay for it.
http://clinicaltrials.gov/ct2/show/N...cr=Open&rank=4
Comment